These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16105047)

  • 21. Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension.
    Stewart T; Jung FF; Manning J; Vehaskari VM
    Kidney Int; 2005 Nov; 68(5):2180-8. PubMed ID: 16221217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.
    Saad SY; Arafah MM; Najjar TA
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):455-60. PubMed ID: 16855841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney.
    Fujihara CK; Malheiros DM; Zatz R; Noronha IL
    Kidney Int; 1998 Nov; 54(5):1510-9. PubMed ID: 9844127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of renal denervation on the development of cellophane-wrap hypertension in rabbits.
    Kline RL; Denton KM; Anderson WP
    Clin Exp Hypertens A; 1986; 8(8):1327-42. PubMed ID: 3545556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure.
    Franco M; Tapia E; Santamaría J; Zafra I; García-Torres R; Gordon KL; Pons H; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
    J Am Soc Nephrol; 2001 Nov; 12(11):2263-2271. PubMed ID: 11675402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat.
    Mattson DL; James L; Berdan EA; Meister CJ
    Hypertension; 2006 Jul; 48(1):149-56. PubMed ID: 16754791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of mycophenolate mofetil on rat kidney grafts with prolonged cold preservation.
    Fuller TF; Hoff U; Rose F; Linde Y; Freise CE; Dragun D; Feng S
    Kidney Int; 2006 Aug; 70(3):570-7. PubMed ID: 16788694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural factors increase blood pressure through the interaction of resistance vessel geometry with neurohumoral and local factors: estimates in rabbits with renal cellophane-wrap hypertension with intact effectors and during neurohumoral blockade.
    Wright CE; Angus JA; Korner PI
    J Hypertens; 2002 Mar; 20(3):471-83. PubMed ID: 11875315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
    Yang CW; Ahn HJ; Kim WY; Li C; Kim HW; Choi BS; Cha JH; Kim YS; Kim J; Bang BK
    Kidney Int; 2002 Jul; 62(1):20-30. PubMed ID: 12081560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S
    Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of sodium to the mechanism of one-kidney, renal-wrap hypertension.
    Haywood JR; Williams SF; Ball NA
    Am J Physiol; 1984 Nov; 247(5 Pt 2):H797-803. PubMed ID: 6496761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.
    Yu XQ; Wu LL; Huang XR; Yang N; Gilbert RE; Cooper ME; Johnson RJ; Lai KN; Lan HY
    Kidney Int; 2000 Oct; 58(4):1469-80. PubMed ID: 11012882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury.
    Ysebaert DK; De Greef KE; Vercauteren SR; Verhulst A; Kockx M; Verpooten GA; De Broe ME
    Kidney Int; 2003 Sep; 64(3):864-73. PubMed ID: 12911536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of mycophenolate mofetil on the progression of adriamycin nephropathy.
    Ryuzo M; Soares V
    Ren Fail; 2001 Sep; 23(5):611-9. PubMed ID: 11725907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
    Zoja C; Benigni A; Noris M; Corna D; Casiraghi F; Pagnoncelli M; Rottoli D; Abbate M; Remuzzi G
    Kidney Int; 2001 Aug; 60(2):653-63. PubMed ID: 11473648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal and systemic vascular conductances in renal wrap hypertension in rabbits.
    Takata M; Denton KM; Anderson WP
    J Hypertens; 1988 Sep; 6(9):719-22. PubMed ID: 3183375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal blood flow and glomerular filtration rate in renal wrap hypertension in rabbits.
    Denton KM; Anderson WP; Korner PI
    J Hypertens; 1983 Dec; 1(4):351-5. PubMed ID: 6398329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate mofetil inhibits regenerative repair in uranyl acetate-induced acute renal failure by reduced interstitial cellular response.
    Sun DF; Fujigaki Y; Fujimoto T; Goto T; Yonemura K; Hishida A
    Am J Pathol; 2002 Jul; 161(1):217-27. PubMed ID: 12107106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction.
    Quiroz Y; Ferrebuz A; Romero F; Vaziri ND; Rodriguez-Iturbe B
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F336-44. PubMed ID: 18077597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.